MDXH.BR Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 gruod. 2023 @ 18:35):

Stats
Dzisiejszy wolumen	14 079.00
Średni wolumen	40 428.00
Kapitalizacja rynkowa	85.63M
EPS	$-0.400 ( 2023-11-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.581
ATR14	$0.202 (6.69%)

Wolumen Korelacja

Długi: 0.04 (neutral)

Krótki: -0.01 (neutral)

Signal:(52.307) Neutral

MDxHealth SA Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MDxHealth SA Korelacja - Waluta/Towar

0.15
( neutral )

-0.11
( neutral )

0.12
( neutral )

0.56
( weak )

-0.30
( neutral )

-0.59
( weak negative )

MDxHealth SA Finanse

Annual	2022
Przychody:	$37.05M
Zysk brutto:	$19.22M (51.87 %)
EPS:	$-0.320

FY	2022
Przychody:	$37.05M
Zysk brutto:	$19.22M (51.87 %)
EPS:	$-0.320

FY	2021
Przychody:	$22.24M
Zysk brutto:	$10.41M (46.82 %)
EPS:	$-0.240

FY	2020
Przychody:	$18.37M
Zysk brutto:	$7.85M (42.72 %)
EPS:	$-0.340

Financial Reports:

No articles found.

MDxHealth SA

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.